


























Dissertation submitted in partial fulfilment of requirements for the MSc in Finance, at the 
Universidade Católica Portuguesa, January 2020. 





- 2 - 
Abstract 
Title: Equity Valuation – Philip Morris International Inc. 
Author: Francisco Machado Pereira da Fonseca 
This dissertation illustrates the equity valuation of Philip Morris International (PMI), one of the 
world-leading companies operating in the tobacco industry, that is traded in the New York 
Stock Exchange. Regarding the valuation process, two techniques were executed. Starting with 
the main one, the DCF-model, projected a price per share of $88.9. On a complimentary basis, 
a relative valuation was executed to better understand the market perception regarding PMI’s 
value. These valuations were followed by sensitive analyses, with the purpose of stress-testing 
the assumptions behind the DCF-model. Lastly, the results were benchmarked with a PMI 
valuation executed by Barclays in December 2019. 




Título: Equity Valuation – Philip Morris International Inc. 
Autor: Francisco Machado Pereira da Fonseca 
Esta dissertação ilustra a avaliação da Philip Morris International, uma das líderes mundiais a 
operar na indústria tabaqueira, cotada na bolsa de Nova Iorque, nos Estados Unidos. 
Relativamente ao processo de avaliação, foram utilizados dois métodos. Começando pelo 
método principal, o Fluxos de Caixa Descontados projeta um preço por ação de $88,9. Como 
método complementar, foi aplicada uma avaliação relativa com o propósito de perceber melhor 
o valor que o mercado atribui à PMI. Após estas avaliações, realizou-se uma análise de 
sensibilidade onde os pressupostos considerados no Fluxo de Caixa Descontados, foram alvos 
de teste. Por fim, comparou-se os resultados obtidos com uma avaliação da PMI realizada pelo 
banco de investimento Barclays, em Dezembro de 2019. 
Palavras-chave: Avaliação, Philip Morris Internacional, Indústria Tabaqueira, Fluxos de Caixa 
Descontados, Avaliação Relativa 
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Introduction 
  
 This dissertation will be developed as an applied project to scrutinize distinct valuation 
models and their practical applications. Having this said, Philip Morris International will be the 
company in focus. To begin with, one will construct a Literature Review, with an explanation 
of the main valuation techniques with the purpose of selecting the most suitable one considering 
PMI characteristics. Moreover, in order to understand the business dynamics and the ecosystem 
in which the firm operates, the following chapters will be an Industry and a Company Overview. 
Thirdly, considering the previous chapters, the Valuation itself will be constructed, based-on 
assumptions that will be further explained, as well as tested. Finally, the result achieved will be 
compared with a valuation performed by an Investment bank, more specifically, with the one 
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1. Literature Review 
“Valuation is neither the science that some of its proponents make it out to be nor the objective 
search for the true value that idealists would like it to become” (Damodaran, 2012). Due to this 
midpoint among certainty and subjectivity, some may argue that “valuation is an art, not an 
exact science”. Thus, as any other kind of art, to comprehend it better, one should debate on its 
different methods and approaches. The main objective of this section is exactly that, 
comprehend and reflect on the different valuation models – theory, inputs, computation process, 
drawbacks, advantages. Only after such analysis, it is possible to know which methods fit better 
to PMI’s characteristics, and therefore, which ones deliver more reliable valuations. 
Relative Valuation 
Multiple Valuation 
In this approach, an asset is evaluated accordingly with its “comparables” already priced 
in the market (Damodaran, 2012). The asset characteristic and, thus the similarities with other 
assets, are the basis of this valuation method. Due to its simple application and intuitive 
comprehension, this practice is commonly used by analysts and investors during valuation 
activities. Also, comparing to other valuation methods, fewer assumptions are taken into 
consideration to implement it.  
Still, it can be easily manipulated, and that condition is even more severe when 
comparing business. As it goes without saying, two companies can ever be completely equal 
regarding profitability or risk, thus the concept of “comparable” is subjective. Besides, as 
mentioned previously, the value is entirely given by the market, and so under or overvaluations 
can be incorporated in the same output. (Damodaran, 2012). As a consequence, it can also 
misguide, as distinctive multiples can lead to contrary conclusions. In one multiple, an asset 
can be traded at a premium, but in another at discount, leading managers and analysts to use 
the ones which fit best their purpose (Koller, Goedhart and Wessels, 2010). 
Yet, it can never be seen as quicker path to reach a valuation, and it is more 
advantageous after executing a valuation applying another approach since allows us to 
benchmark the valuation achieved and recognize the differences between the asset valued and 
its “comparables” (Fernández, 2001 & Koller, Goedhart and Wessels, 2010). 
In order to overcome the pitfalls of this approach and assist companies to apply 
multiples more accurately, one should apply four principles: 1) To select the peer group, find 
firms with similar forecasts for ROIC and growth; 2) Avoid historical multiples based on past 
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earnings, and use forward-looking multiples based on forecast; 3) Give preference to enterprise 
value multiples rather than P/E multiples - vulnerability to capital structure changes and volatile 
earnings; 4) Correct the EV/EBITA multiple for non-operating items as pensions, employee 
stock options, operating leases and excess cash and other non-operating assets (Koller, 
Goedhart and Wessels, 2010). 
 After computing all multiples, to increase their performance rather than use the mean or 
the median of the peer group, the best measure is the harmonic mean (Liu, Doron and Jacob, 
2001).  
The Peer Group 
Selecting an accurate peer group is the key to reach a realistic valuation adopting 
multiples. Even if the multiples are calculated correctly, having an erratic peer group sample 
leads to unrealistic valuations.   
A simple method to identify the peer group is to use the Global Industry Classification 
Standard (GICS) system or the Standard Industrial Classification (SIC) codes, although this 
groups tend to be too inclusive, making possible that companies with different core business 
end up in the same group (Koller, Goedhart and Wessels, 2010).  Lee and Bhojraj (2001), 
suggest an alternative way of finding the correct peer group. According to them, the “choice of 
comparable firms should be a function of the variables that drive cross-sectional variation in 
a given valuation multiple”. For instance, regarding the EV/Revenues multiple, a comparable 
business would be nominated based on “variables that drive cross-sectional differences in this 
ratio”. Further, the authors use these variables, alongside with the ones suggested by valuation 
theory, to create the “warranted multiple” for each firm within a certain dataset, and then 
include the ones with similar valuation multiples to for peer group.  
 
Discounted Cash Flow Valuation (DCF) 
The DCF approach comes along with a fundamental rule that defines all the method itself, “the 
value of any asset is the present value of expected future cashflows that the asset generates”, 

















CF = cash flow  
    i = discount rate  
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   n = time periods from one to infinity 
 
 There are thousands of DFC models, nevertheless, Damodaran (2012) stresses out the 
three paths to discounted cash flow valuation, and two of them will be described in this section. 
One only takes into account the equity pole of the business, whereas the other considers the 
total value of the company - it also incorporates the other claim holders of the company.  
 When working with DCF model, it is mandatory to comprehend that the value of an 
asset comes from the relation between with three major aspects, which are, Cash Flow, Risk 
and Timing (Luerhman, 1997). The future value is generated by the sum of all expected cash 
flows, nevertheless, those cash flows are not guaranteed, so it is necessary to discount them. 
Since the cash flows are uncertain and bear risk, investors demand a certain rate to discount 
those cash flows. And finally, those cash flows are not generated at the same time, therefore it 
is mandatory to time all of them (Luerhman, 1997). At a certain point in time, those cash flows 
are all joined together in the Terminal Value, which will be explained further. 
Generally speaking, the FCF is the addition of all sources of cash minus the capital 
expenses needed for the firm to continue to operate at the expected rate. In addition, it should 
also take into consideration “the capital equipment, cash to finance working capital, and any 
additional debt”. An alternative to assess the CF’s is to base the forecast on the firm’s financial 
history, by constructing a financial model of the firm (Gilbert, 1990). In order to achieve the 
Free Cash Flow to the Firm, the following formula should be applied:  
 
𝐹𝐶𝐹𝐹 = 𝐸𝐵𝐼𝑇 (1 − 𝑇𝑎𝑥 𝑅𝑎𝑡𝑒) + 𝐷&𝐴 −  ∆ 𝑁𝑒𝑡 𝑊𝑜𝑟𝑘𝑖𝑛𝑔 𝐶𝑎𝑝𝑖𝑡𝑎𝑙 − 𝐶𝑎𝑝𝑒𝑥  
 
The Free Cash Flow to Equity calculation is slightly different since it only takes into account 
the value of Equity. It demonstrates total value claimed by the shareholders, and to reach that 
amount it is necessary to compute the following formula: 
 
𝐹𝐶𝐹𝐸 = 𝐶𝑎𝑠ℎ 𝑓𝑟𝑜𝑚 𝑂𝑝𝑒𝑟𝑎𝑡𝑖𝑜𝑛𝑠 − 𝐶𝑎𝑝𝑒𝑥 + 𝑁𝑒𝑡 𝐷𝑒𝑏𝑡 𝐼𝑠𝑠𝑢𝑒𝑑  
 
 Regarding risk, the required discount rate, both paths consider different levels of risk. 
To value Equity, only the risk that shareholders bear, and consequently the rate of return asked 
to bear that risk, is taken into consideration – cost of equity ( 𝑟𝑒). To discount the CF to the 
firm, a different rate of return is required, since in this case both Equity and Debt participate in 
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the equation. To account for that, normally the discount rate used is the Weight Average Cost 
of Capital (WACC) (Luerhman, 1997).  
 As advocated previously, regarding Timing, the major concern is computing the 
Terminal Value. Cash Flows cannot be estimated accurately for indeterminate periods, so, at a 
certain time, the Terminal Value is incorporated in the formula to solve that problem 
(Damodaran, 2012). It is important to underline that the estimation of the TV is one of the most 
essential parts of the DCF approach, since in counts for over 50% of the total value of an asset 
(Gilbert, 1989). Further in this dissertation, the Terminal Value computation will be discussed 
in more detail.  
The formula of the DCF model regarding the Value of Equity, adding what was state before, is 
the following: 












𝐶𝐹𝑛 = Cash Flow d 
   𝑟𝑒 = cost of equity  
 TV = Terminal Value 
It is important to keep in mind that the “cost of equity is a function of the levered beta”. Parrino 
(2005) underlines this since changes in the value of debt affect the debt to capital ratio and, 
consequently, the value of the firm. Thus, for the cost of equity to be consistent with the CF 
projection, is mandatory to forecast as well, the debt to equity ratios that are coherent with the 
interest within the CF projections. All of these adjustments can be hard to implement and may 
involve numerous iterations over the calculations to reach a reasonable outcome. Therefore, it 
is simpler to utilize the WACC to price the entire business and then deduct the value of debt, 
to forecast the value of equity (Parrino, 2005). 
Regarding the Value of the Firm, the general DFC formula is: 










 𝐹𝐶𝐹𝐹𝑛 = Free Cash Flow to the Firm 
 𝑊𝐴𝐶𝐶 = Weight Average Cost of Capital  
          g = Growth rate 
       TV = Terminal Value 
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“The DCF valuation approach is theoretically the most “correct” valuation approach” 
(Gilbert, 1989), nevertheless it reveals some drawbacks as well. Damodaran (2012) presents us 
with some situations, in which this approach has difficulties to be applied to: 
  “Firms in trouble” - Whenever a company is facing a strong probability of bankruptcy, 
forecasting its earning is a difficult task. If they do present negative cash flows, this approach 
fails since it perceives the value of a company as a “going concern providing positive cashflows 
to its investors”. Thought, even if the firm subsists, the forecast period needs to be extended 
until the cashflow delivers positive earning, otherwise, the approach will output a negative 
value for the equity or the firm.  
 “Firms in the process of restructuring” - The DFC approach depends deeply on the 
capital structure of a company, or in other words, the riskiness of the firm. Thus, if a forecast 
is done based on the historical data and for some reason the company changes its capital 
structure, the expected cash flow will not be discount at the update cost of capital, which 
severely compromises the final result.  
 “Cyclical firms” - The profitability of these companies is very much correlated by the 
state of the economy, “rising during economic booms and falling during recessions. When 
using the DCF approach in one of these periods, without considering the cyclicality of the 
company, the value attributed will always be over or underestimated. 
 
Adjusted Present Value (APV)  
As stated previously, this method is one of the paths to discounted cash flow valuation. 
Differently from the WACC, instead of estimating the value of a firm as a whole, the “APV’s 
approach analyzes financial maneuvers separately and then add their value to that of the 
business” (Luehrman 1997). This approach first values a firm considering that it is completely 
financed with equity, and then sums up the results of the company’s financing assessments to 
this unlevered company value (Parrino 2005). 
According to Luerhman (1997), when implementing this approach, firstly, one should 
“layout the base case cash flows”, by constructing financial projections – cash flows – as in 
any DFC approach. Then, the next step is to “Discount the flows using an appropriate discount 
rate and terminal value”. In this case, the appropriate one is the cost of equity when the 
company has no debt since this approach considers an all-equity capital structure. The general 
formula is the following (Parrino, 2005): 
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𝑉𝑎𝑙𝑢𝑒𝑈𝑛𝑙𝑒𝑣𝑒𝑟𝑒𝑑 𝐹𝑖𝑟𝑚  =  ∑
𝐹𝐶𝐹𝐹𝑡





𝑈𝑛𝑙𝑒𝑣𝑒𝑟𝑒𝑑 𝑊𝐴𝐶𝐶 = Cost of equity 
                       𝐹𝐶𝐹𝐹𝑡 = Free Cash Flow to the Firm 
 
Thus, according to CAPM, the general formula for the Unlevered WACC is the following 
(Parrino, 2005): 
𝑈𝑛𝑙𝑒𝑣𝑒𝑟𝑒𝑑 𝑊𝐴𝐶𝐶 =  𝑟𝑓 + 𝛽Α ×  𝑀𝑎𝑟𝑘𝑒𝑡 𝑅𝑖𝑠𝑘 𝑃𝑟𝑒𝑚𝑖𝑢𝑚 
where, 
𝑟𝑓 = Risk-free rate 
𝛽Α = Asset beta 
𝑀𝑎𝑟𝑘𝑒𝑡 𝑅𝑖𝑠𝑘 𝑃𝑟𝑒𝑚𝑖𝑢𝑚 = expected market return less the risk-free rate  
 
After, the third step consists of “Evaluate the financing side effects”. One of the side effects is 
the interest tax shield due to the deductibility of interest payments on the corporate tax return. 
To discount this side effect the appropriate rate is the cost of debt since “tax shields will be 
realized when the firm is able to make its debt payments; therefore, the tax shields are about as 
risky as the debt” (Parrino, 2005). The general formula of this side effect is the following: 
 
𝑉𝑎𝑙𝑢𝑒 𝑜𝑓 𝑇𝑎𝑥 𝑆ℎ𝑖𝑒𝑙𝑑 =  ∑






 For that reason, one might suggest that according to APV more debt is always beneficial. 
Since in reality that’s not true, due to financial distress, analysts should take into account the 
benefits of debt – tax shield –, as well as the costs – bankruptcy costs (Parrino, 2005). Which 
lead us to the next stage, called “Add the pieces together to get the initial APV. The general 
formula for the APV approach is the following: 
 
𝑉𝑎𝑙𝑢𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑓𝑖𝑟𝑚
= 𝑉𝑎𝑙𝑢𝑒𝑈𝑛𝑙𝑒𝑣𝑒𝑟𝑒𝑑 𝐹𝑖𝑟𝑚 + ∑




− 𝜋𝑎 × 𝑃𝑉𝑏𝑎𝑛𝑘𝑟𝑢𝑝𝑡𝑐𝑦 𝑐𝑜𝑠𝑡𝑠  
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where,  
𝜋𝑎 = Probability of Bankruptcy 
 𝑟𝑑 = Cost of Debt 
 
 One of the main benefits of this model compared to others is the fact that one can 
forecast CF and appropriate discount rates separately for each section – interest tax shield, 
margin improvement, net working capital improvement, assets sales – and, consequently, 
obtain more accurate assessments of value (Luehrman, 1997 and Damodaran 2012). In addition, 
it also adapts better whenever there are changes in the debt structure of a company. 
 Nevertheless, there is no consensus regarding the APV approach. Booth (2002), argues 
that this method should be used alongside with other valuation methods, due to its regular 
unreliability regarding some assumptions of the model – estimation of the unlevered cost of 
equity and the optimal amount of debt. The advantages of this approach are even more evident 
in circumstances as leveraged buyouts, real estate financing, project financing and structured 
financing (Booth, 2002). 
 
Dividend Discount Model (DDM) 
Whenever an investor acquires shares in the market, the only cash flow she receives in return 
is the dividend, for that matter, “the simplest model for valuing equity is the dividend discount 
model” (Damodaran, 2012). Similarly to the DFC model, the value of a stock is the present 
value of expected cash flows it delivers, dividends in this case (Parrino, 2005). Again, as the 
DCF model, this approach lies in the present value rule, therefore the expected cash flows are 
discounted at the riskiness of the business, in this case, at the cost of equity.  
 One of the versions of this model is “The Gordon Growth Model”, and its main driver 
is considering that future dividends will grow at a constant rate (g). The general formula of this 
model is the following: 
 





DPS1 = Expected Dividends one year from now (next period)  
𝑟𝑒= Required rate of return for equity investors 
g = Growth rate in dividends forever  
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Due to its simplicity, this version is extremely sensitive to the inputs for the growth rate 
(Damodaran, 2012). If it is incorrectly calculated, can lead to misleading results or even 
illogical results, when the growth rate converges to the cost of capital, which as an exponential 
effect on the value of the stock. And, if the growth rate goes beyond the cost of capital, the 
value of the stock turns negative, which is impossible to occur “because equity is an option on 
the underlying assets of the firm and options cannot have negative values” (Parrino, 2005). 
 In order to overcome the unrealistic constant growth rate, there is another version of the 
Dividend Discount Model, the “Two-stage Dividend Model. In this case, there are two stages 
of growth, an unsteady initial one, and a subsequent constant rate. The general formula of this 
model is the following (Damodaran, 2012): 
 








(1 +  𝑘𝑒,ℎ𝑔)
𝑛  where 𝑃𝑛 =
𝐷𝑃𝑆𝑛+1




DPSt = Expected dividends per share in year t 
ke = Cost of Equity (hg: High Growth period; st: Stable growth period)  
Pn = Price (terminal value) at the end of year n 
 g = Extraordinary growth rate for the first n years 
 gn = Steady state growth rate forever after year n  
 Although it tries to solve some problems, this version comes along with some drawback 
itself. The first one it the uncertainty in identifying the exact duration of the high growth period, 
which can result in a price overestimation (under) of the price if a longer (shorter) period is 
incorrectly assumed. Secondly, this version expects a sudden drastic change in the growth rate 
instead of considering gradual changes over time, which is more realistic (Damodaran, 2012).  
As a general review, Damodaran (2012) stresses out the fact that since Dividend Discount 
Models only considers dividends, these models underestimate firms that, in order to accumulate 
cash or to reinvest within its business, “payout little in dividends”. 
Finally, it is important to underline the fact that these models can be applied as a backup 
of other valuation methods, and also as a standalone approach for estimating the intrinsic value 
of a share straight away (Parrino, 2005). 
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WACC Assumptions 
The Cost of Capital 
“In an enterprise valuation, free cash flows are available to all investors”, thus the appropriate 
discount rate for FCF must include the risk that all investors bear (Koller, Goedhart and 
Wessels, 2010). Consequently, the WACC is the proper rate of return to discount the cash flow, 
by merging the rate required of both equity holders and debt holders. The general formula for 









D = Market Value of Debt 
E = Market Value of Equity 
𝑘𝑑 = Cost of Debt 
𝑘𝑒 = Cost of Equity 
𝑇𝑚 = Marginal tax rate 
 
 It is pertinent to refer that both Equity and Debt value should be computed according to 
its market value, instead of the book value. In addition, one also needs to incorporate da effect 
of the marginal tax rate on the cost of debt, since the tax shield resultant from interest has been 
eliminated from the FCF. Thus, considering that the ITS – interest tax shield - has value, it 
needs to be integrated into the assessment, by decreasing the WACC (Koller, Goedhart and 
Wessels, 2010). 
 
The Cost of Debt 
The cost of debt represents the expected return debtholders count on achieving on their 
investments and it needs to include a premium related to the default risk (Damodaran, 2012). 
Regarding its estimations, “the cost of debt for a company with investment-grade debt, yield to 
maturity is a suitable proxy” and “should be calculated on liquid, option-free, long-term debt 
(Koller, Goedhart and Wessels, 2010).  
 On the other hand, for firms with only short-term bonds or whose debt trades 
infrequently, one should consider the firm’s debt rating to estimate the yield to maturity, and 
consequently the cost of debt. This is justified by the fact that short-term bonds do not represent 
the firm’s FCF duration and that bonds rarely traded induces to outdated bonds prices. These 
conditions, consequently, lead to outdated yields (Koller, Goedhart and Wessels, 2010). 
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The Cost of Equity 
As advocated previously, the rate of return required by equity holders bear the risk of the firm 
represents the cost of capital, it represents the expected return equity holders ambition 
(Damodaran, 2012). In order to achieve the appropriate, expected return, it is common practice 
to use the CAPM, and the formula is the following (Parrino, 2005):  
 
𝐶𝑜𝑠𝑡 𝑜𝑓 𝐸𝑞𝑢𝑖𝑡𝑦 = 𝑟𝑓 + 𝛽 × [𝐸(𝑟𝑚) − 𝑟𝑓] 
where,  
𝑟𝑓 = Risk-free rate 
𝛽 = Beta 
𝐸(𝑟𝑚) = Expected market return 
𝐸(𝑟𝑚) − 𝑟𝑓 = Expected market risk premium (MRP) 
 
    Risk-free rate 
In a risk-free investment, an investor knows from the beginning that the actual return 
equals the underlying expected return. This is only possible when two requirements are fulfilled 
- “no default risk” and “no reinvestment risk” (Damodaran, 2008).  
Only governments and central banks can issue securities with a risk-free rate since they 
are the ones who control the printing of currency, therefore they should be able to comply with 
their promises, in nominal terms at least. For firms based in the US, one should adopt the 10-
year government STRIPS, and for European ones 10-year German government bonds, since 
they are traded more often and present “lower credit risk than bonds of other European 
countries” (Koller, Goedhart and Wessels, 2010).  
The second condition is linked with the first one since “for an investment to have an 
actual return equal to its expected return, there can be no reinvestment risk”. Therefore, the 
suitable risk-free rate to apply in the cost of equity calculation is a government zero-coupon 
bond that matches the investment lifetime (Damodaran, 2008). 
Parrino (2005) advocates that there are three measures of the risk-free rate, being long-
term government bonds a proxy for long-term investments, intermediate-term Treasury notes 
for a time span between 5 to 7 years, and for short-term investments an investor should consider 
the short-term Treasury bills.  
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Finally, to estimate the risk-free rate one should utilize government bond yields 
expressed in the same currency as the firm’s cash flows, and monitor if the inflation rate 
assumed in the cash flows calculation is coherent with the inflation rate assumed in the 
government bond rate selected (Koller, Goedhart and Wessels, 2010). 
 
Beta 
“The core question for a company’s cost of equity is how to estimate a company’s risk relative 
to the market, and consequently beta” (Koller, Goedhart and Wessels, 2010). The authors just 
state, advocate that beta is an estimate of the firm’s exposure to the market risk. In order to 
estimate the firm’s beta in the industry sample, one should execute a linear regression, as 
indicated beneath (Koller, Goedhart and Wessels, 2010): 
 
𝑅𝑖 =  𝛼 + 𝛽 × 𝑅𝑚 +  𝜀 
where,  
  𝑅𝑖 = stock’s return 
   𝛽 = raw beta 
𝑅𝑚 = market portfolio return 
 
As betas tend to move toward the overall average, which is one, there is an adjustment process 
named Smoothing. In industries where comparable businesses are hard to find, this method can 
be useful (Koller, Goedhart and Wessels, 2010 and Damodaran, 2012). The beta can be adjusted 
by adopting the following method (Bloomberg): 
 
𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑 𝐵𝑒𝑡𝑎 = 0.33 +  0.67 (𝑅𝑎𝑤 𝑏𝑒𝑡𝑎) 
 
Market Risk Premium 
Generally speaking, the market risk premium “represents the risk premium required by 
investors for bearing the risk of owning the market portfolio”, or in other words, is simply “the 
difference between the expected return on the market - 𝑅𝑚 - and the expected risk-free rate - 
𝑅𝑓”(Peterson, Peterson, 1996). While there are still various approaches to estimate this 
measure, one commonly uses the historical market risk premium approach, which is basically, 
“subtracting the return on government bonds from the return on a large sample of companies 
over some time frame” (Koller, Goedhart and Wessels, 2010).  
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 Nevertheless, some may argue about its pitfalls. Thus, to overcome them, one may 
follow the suggestions gave by Koller, Goedhart and Wessels (2010). The authors suggest 
calculating the risk premium based on long-term government bonds since long-term bonds pair 
better the duration of the firm’s CF’s than short-term. Also suggest using the longest period 
possible, to decrease the estimation errors, and to use an arithmetic average of longer-dated 
intervals, instead of a geometric one.  
 Still, “historical risk premiums for markets outside the United States cannot be used in 
risk models” (Damodaran, 2012). To overcome this issue, Damodaran recommends an 
adjustment, by adding a country risk premium - country’s default spread – to the equity risk 
premium from the historical premiums of representative markets – Europe, US, etc.). The 
general formula that represents the adjustment is the following:  
 
𝑀𝑎𝑟𝑘𝑒𝑡 𝑅𝑖𝑠𝑘 𝑃𝑟𝑒𝑚𝑖𝑢𝑚 = 𝑃𝑟𝑒𝑚𝑖𝑢𝑚 𝑓𝑜𝑟 𝑀𝑎𝑡𝑢𝑟𝑒 𝐸𝑞𝑢𝑖𝑡𝑦 𝑀𝑎𝑟𝑘𝑒𝑡 + 𝐶𝑜𝑢𝑛𝑡𝑟𝑦′𝑠 𝐷𝑒𝑓𝑎𝑢𝑙𝑡 𝑆𝑝𝑟𝑒𝑎𝑑   
 
Growth Rate 
“The most critical input in valuation is the growth rate to use to forecast future revenues and 
earnings, and there are three sources for growth rates” (Damodaran, 2012).  
 The first one takes into consideration the firm’s historical returns and it is very useful 
to estimate the value of stable companies. Nevertheless, when valuing high growth firms, the 
historical growth rate is not suitable, since sometimes it cannot be estimated and when it’s 
possible “it cannot be relied on as an estimate of expected future growth”. 
 The second source is the estimate of growth indicated by equity research analysts who 
follow the firm. According to Damodaran (2012), even though these analysts may be privy to 
information that the market does not have access, “the quality of growth estimates, especially 
over longer periods, is poor”, which can guide to erratic and inconsistent valuations.  
 The last source to guesstimate the growth rate is the firm’s fundamentals. The 
connection between fundamentals and growth depends on which growth rate one is estimating. 
For example, to estimate growth in profits, one should replace the retention ratio with the equity 
reinvestment rate, or to evaluate growth in operating income, one should use return on capital 
and reinvestment rate. By measuring these inputs, in a sense, one is estimating the firm’s 
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Terminal Value 
 As one cannot forecast cash flows indeterminately, once it stops being an accurate 
estimate, it needs to stop. To address this problem one should compute the Terminal Value, 
which represents the value of the firm at that point in time (Damodaran, 2012).  There are 
three methods to compute this value - Liquidation Value, Stable Growth Model and Multiple 
Approach (Damodaran, 2012). The first one considers the circumstances in which the firm 
ceases its operations and sell all the assets at a certain time in the future. Basically, this approach 
bases its valuation on the book value of the assets and then adjusts it for any inflation during 
the period. Since there is no indication about Philip Morris shutting down its business in the 
near future, this method will have no practical approach in this dissertation.  
 Moving to the next method, firms can extend their time span by reinvesting some of 
their cash flow into the firm. Following that thought, Sable Growth Model assumes that cash 
flow will grow at a constant rate and therefore firms can thrive perpetually. The general formula 
for the Terminal Value regarding this approach is the following (Damodaran, 2012). 
 





r = Cost of capital 
g = Stable growth rate 
 
 On the other hand, for the Multiple Approach “the value of a firm in a future year is 
estimated by applying a multiple to the firm’s earnings or revenues in that year”. Nevertheless, 
according to Damodaran (2012), the most reliable path to measure the Terminal Value within 




After mentioning all these methods and procedures, it is possible to determine which 
ones suit best to PMI’s characteristics, and, therefore, will lead to more reliable valuations. The 
primary method chosen is the DCF-WACC, since none of its principal pitfalls affect PMI – 
changes in capital structure, cyclicality or bankruptcy. On the other hand, Philip Morris is not 
facing any circumstances such as leveraged buyouts, real estate financing, project financing 
and structured financing, therefore the APV model will not be considered. On a secondary basis, 
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the relative valuation, due to its beneficial characteristics – straightforward comprehension, 
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2. Industry Overview  
More than ever, the tobacco industry’s future is facing uncertainty, where different 
regions around the globe are adopting distinct patterns. In order to comprehend these 
tendencies, first, one should understand what affects consumer behavior regarding tobacco 
products. According to World Health Organization (WHO), the consumption of tobacco is 
mainly driven by the following factors: 
– Price of tobacco products  
– Disposable income of the consumer  
– Demographic characteristics of the population (e.g., gender, age, ethnicity)  
– Socio-economic status of the population (e.g., education, employment status)  
– Rural versus urban area of residence  
– Tobacco control interventions (e.g., smoking restrictions, bans on advertising and 
promotion of tobacco products)  
– Knowledge and information about the health effects of tobacco use 
 Regarding all these factors, WHO states that price and consumer income are the main 
drivers of tobacco products’ demand. Also, WHO explains that, independently of the income 
status of a given country, the increase in prices leads generally to a consumption decline. 
Furthermore, especially in low- and medium-income environments, which aggregates 80%1 of 
the world's smokers, an increase in income provokes an upper movement in tobacco 
consumption. Whereas, in wealth settings, an increase in income, shifts the consumers’ demand 
for higher-priced products. 
 
Smoking Population 
WHO estimates that nowadays there are 1.11 billion in the world, of which 85%1 are 
male. Despite the world’s growing awareness of the negative effects of tobacco, by 2025, it is 
projected a very low reduction of the total smoking population - CAGR of -0.2%1. Although 
the difference is not significant on a global level, two distinct forces are driving forecast. Both 
Europe and America, are expected to report a downer trend - CAGR of -1.6%1 -, whereas, 
African and Eastern Mediterranean, are expected to record an upper trend - CAGR of 2.6%1. 
Moreover, while breaking down the projections by income disposable, there are also two 
different aspects affecting future results. High-income and Upper middle-income, by 2025, is 
 
1 World Health Organization - global report on trends in the prevalence of tobacco smoking 2000-2025 - Second edition 
 





- 24 - 
expected to report a CAGR of -0.92%2, whereas, Lower middle-income and Low-income have 
a projected CAGR of 1%2. 
 
Market Size and Value 
 The tobacco industry in 2017 reported a market value of $663.8B3, and, until 2026 is 




As previously mentioned, consumer preferences across different regions of the globe 
are shifting. Nowadays, the demand for these products is moving from developed regions to 
emerging markets, mainly in Asia and African. The reasons behind could rely on increasing 
disposable income levels, rising population and lower government control. On the other hand, 
in developed regions such as Europe and North America, the demand for cigarettes is facing 
several threats. Due to the increasing health awareness, government agencies are increasing the 
regulations and taxations against tobacco products, which consequently declines the smoking 
prevalence across these populations.  In terms of volume, the market reported a CAGR 
of 1.5%4 from 2011 until 2018, reaching a total volume of 8.24 million tons. Furthermore, 
between 2019 and 2024, the total tobacco volume is expected to report a CAGR of 1.4%4, 
around 0.1 tons every year. In addition to all economic factors mentioned above, the 
introduction of various premium tobacco - long, flavored, colored, etc. - and e-cigarettes by the 
main players has positively contributed to the prosperity of the industry. 
 Moreover, the promotion of Heated Tobacco Products (HTP’s) is another important 
factor that will deeply influence the market. As mentioned before, the world is increasingly 
 
2 World Health Organization - global report on trends in the prevalence of tobacco smoking 2000-2025 - Second edition 
3 Stratistisc MRC - Tobacco Market - Global Market Outlook (2017-2026) 
4 IMARC Group - Tobacco Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 
Exhibit 1 – Tobacco Industry Market Size and Value    
Source: Stratistisc MRC  
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more concerned about health matters and consumers are starting to search for less-harmful 
options. HTP’s have been precisely introduced in the market to meet those expectations, since 
this device does not burn the tobacco, but it heats it instead - which allegedly produces less 
aerosol. Consequently, these products are expected to report a CAGR of 19.3%5 from 2019 to 
2025. Due to the significantly large smoking population and social acceptance, the Asia-Pacific 
region – the majority - and Europe will hold almost the entire portion of the overall market of 
HTP’s products. Some main players, such as PMI, BAT and Japan Tobacco already started to 
develop and commercialize these types of products. 
 
Excise Taxes 
Just like fuel and alcohol, tobacco products are also under strict excise taxes. This type 
of taxation is not consistent worldwide, thus different countries can apply distinct taxation 
systems. In some cases, specific excises taxes are added to the retailing price. The US, for 
instance, follows this system by adding a certain amount - $1.816 per pack on average - over 
the retailing price. There is another system named ad valorem, in which a given % is applied 
over the retailing price. In Europe, both systems are applied, thus there is an excise tax of at 
least 90€7 per 1000 cigarettes and also an excise tax over the weighted average retail selling 
price of at least 60%.7 
According to WHO, these taxation methods are one of the most effective methods to, 
simultaneously, reduce tobacco consumption - especially for young and low-income people - 
and increase government revenue. Regarding the relation between tax excise and consumption, 
a tax that raises tobacco prices by 10% will have a negative effect on consumption of 4%8 in 
high-income countries and about 5%8 in low and middle-income countries. Thought, high 
excise taxes over tobacco products are not commonly used since only 388 countries - 14% of 
the world’s population - impose a tax of, at least, 75%8 over the retail price. 
 
Types of Tobacco products 
Due to scientific and technological developments, nowadays there are several products 
classified as tobacco. The main products available in the market are the following: 
– Cigarette (tobacco, filter and paper wrapping) 
 
5 6W Research - Global Heat-Not-Burn Tobacco Product Market (2019-2025): Market Forecast  
6 The Tax Burden on Tobacco, 1970-2018 
7 Directive 2011/64/EU 
8 World Health Organization - Relationship between tax and price and global evidence 
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– Cigars, Little Cigars and Cigarillos (cured tobacco encased in leaf tobacco or a 
substance containing tobacco) 
– Dissolvable Products (sold as lozenges, strips, or sticks)  
– Electronic Cigarettes (heats a liquid that usually contains nicotine from tobacco and 
flavorings, into an aerosol that is inhaled)  
– Heated Tobacco (instead of burning, heats the tobacco) 
– Smokeless Products (chewing tobacco and moist snuff) 
Market Competition 
The tobacco industry is characterized by being a highly concentrated market since the 
three main manufactures cover more than two-thirds of the total market share - PMI, British 
American Tobacco (BAT) and China National Tobacco Corporation (CNTC). The major 
players of this sector already possess a strong brand awareness, as well as, established 
distribution networks, which represent tremendous barriers for new entrants. Regarding both 
revenue and unit volume, CNTC is the dominant tobacco player, followed by PMI and BAT, 







3. Company Overview  
 Philip Morris is an American-based company that operates within the Tobacco Market. 
The company started its operations in 1987 and, since then, its core business has been the 
manufacture and sale of cigarettes. In 2016, the firm started to produce a new line of products 
called IQOS - smoke-free products and other nicotine-containing products. The company 
manages six of the world’s top 15 international cigarette brands such as Marlboro, Bond Street, 
Exhibit 2 & 3 – 2018 Net Revenues and 2017 Market Share of leading tobacco companies  
Source: Revenues - Thomson Reuters EIKON; Market Share: MarketLine  
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Chesterfield, L&M, Parliament and Philip Morris. Their presence is spread throughout 1809 
markets - all outside of US - in which “they hold the number one or number two market share 
position”. By the end of 2018, the company directly owned 449 manufacturing facilities and 
employed seventy thousand people, worldwide. 
 
Strategy 
 Since 2016, PMI has been dramatically changing their business strategy due to the 
world’s increasing awareness regarding the health effects provoked by cigarette smoking. 
Nowadays, consumers are looking for less harmful but still satisfying alternatives. As a result, 
to address this shift in consumers’ demand, PMI committed to transform “the cigarette 
company to one that is focused on Reduced-Risk Product”. Thus, from 2016 on, they started 
groundbreaking researches to develop and sell smoke-free products that, while not risk-free, 
are still a better option than the previous cigarettes. Therefore, their objective is to gradually 
replace cigarettes with less-harmful alternatives – Reduced-Risk Product (RRP) - and become 
a global leader in this new segment of the tobacco industry.  
The RRPs are characterized as products with the potential of inducing “less risk of 
harm” to smokers, comparing to cigarettes. The major difference relays on the fact that these 
products do not burn tobacco but heat it instead. By doing so, RRPs produce an “aerosol that 




 PMI divides its business through two major approaches - geographically and by product. 
Regarding the first one, the company’s revenue is divided into the following segments: 
1. European Union - includes all European Union countries, as well as, Norway, 
Switzerland and Iceland; 
2. Eastern Europe - aggregates Southeast Europe, Ukraine, Israel, Russia and Central Asia;
  
3. Middle East & Africa - includes Africa, Middle East and Turkey 
4. South & Southeast Asia - covers Indonesia, Philippines and other surrounding markets 
 
9 PMI 2018 Anual Report 
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5. East Asia & Australia - consists of Australia, Japan, South Korea, China, as well as, 
other markets in the region 
6. Latin America & Canada - combines South America, Central America, Mexico, the 
Caribbean and Canada; 
The weight of each segment within Total Net sales has not suffered major differences, over the 
last years. As one can observe through Exhibit 5, Eastern Union is by far the principal segment 
of PMI with 33.4% of total net sales, whereas Latin America & Canada is placed as the smaller 
market covering only 7.48% of the firm’s total net sales. 
 As previously mentioned, the tobacco company also broke down its revenues on a 
product basis. In this case, the division results in only two sections, Combustible Products and 
Reduced-Risk Products. The first category includes predominantly American blend cigarette 
brands - Chesterfield, Marlboro, Philip Morris, etc. On the other hand, the RRP category covers 
IQOS smoke-free products, which includes nicotine-containing vapor products and heated 
tobacco. From all the 180 markets covered by PMI, the latest category, since the beginning of 
2019, was already being commercialized in 44 markets.  
 Due to PMI’s changing strategy, the weight of each category has considerably changed 
over the last years. While in 2016, the year RRPs were introduced, this section represented only 


























Exhibit 4 & 5 – Segment Distribution ang Geographical Distribution 
Source: PMI Q3 report 
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Ownership Structure, Stock Market, Dividends  
Regarding the ownership structure, 75%10 of PMI shares are held by institutional 
investors, which is higher than the standard in the tobacco industry. Within that group, the top 
10 shareholders gather up to 32%10 of outstanding shares. The Vanguard Group is the main 
investor of PMI with 7.9%10 of outstanding shares followed by BlackRock with 6.1%10.  
PMI became a public company in 2008 when it was listed at the New York Stock 
Exchange, where nowadays presents 1,552 million outstanding shares. As Exhibit 6 reveals, in 
the last 5 years, PMI stock has generally followed the patterns of the S&P 500 index. Over that 
period, the shares of the tobacco company reported a return close to zero, although displaying 
a volatility of 12.6%. 
 
Since 2008, PMI has been gradually increasing its dividend payments. More precisely, 
since it became a public company, dividends have reported a CAGR of 8.9%11,  




10 Thomson Reuters EIKON 
11 PMI Q3 Financial Report 
Exhibit 7 – Dividend payments from 2015 to 2019  
Source: PMI respective annual reports 
Exhibit 6 – PMI price Performance against S&P 500 
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Historical Performance  
In this section, it will be analyzed and discussed the past performance of all necessary 
inputs to determine the valuation of Philip Morris. 
 
Net Sales 
PMI, when reporting the sales performance, gives greater importance to the measure 
“Net Revenues” than to “Revenues”. The difference between these two is the Excise Taxes 
imposed by the governments. Over the last years (footnote between 2015 and 2018), Net 
Revenues have represented 36.1% of Revenues. Since PMI possesses no control over this tax, 
“Net Revenues” is assumed as the principal measure when referring to Sales. Thus, in this 
dissertation one will follow that same approach. 
 On a global view, from 2015 until 2018, Net Revenues have reported a CAGR of 3.4%, 
which goes in line with the growth rate of the tobacco industry. Regarding the year of 2019, 
until August, Net Revenues remained quite constant on YoY terms, recording only a decrease 
of 0.15%. 
 Starting with a geographical breakdown: 
   1.European Union, from 2016 to 2018, reported a CAGR of 6.7%. The CAGR 
increase felt, was highly influenced by the 2018 YoY increase of 11.8%, which can be primarily 
explained by the appreciation of the US Dollar over the Euro, and by a favorable pricing 
variance and increase of heated tobacco volume sold, on a secondary base.  
  2.Eastern Europe recorded a CAGR of 8.4% over the previously mentioned 
period., which was driven by positive pricing variance and by a rise of heated tobacco volume 
sold.  
  3.Middle East & Africa, the results progressed in the other way around, since it 
reported a CAGR of -4.6%. The main driver of this decrease was the 2017 YoY Net Sales 
Results, which record a decline of 11.7% caused by negative currency variance. 
  4.South & Southeast Asia reported a CAGR of 2.9%, which was primarily driven 
by favorable price variance.  
  5.Regarding East Asia & Australia Net Revenues results, PMI accounted for 
completely distinct results for 2017 YoY – an increase of 48.8% - and 2018 YoY – a decline of 
12.4%. The 2017 YoY results were driven by an increase in price and on sales volume, whereas 
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YoY 2018 YoY results were caused by an increase in tax-driven retail prices in Japan and 
Australia. 
  6.Latin America & Canada reported a steady growth, which led to a CAGR of 




When doing a breakdown by product, the two categories reported completely different 
trends, due to the radical strategy transition. Starting with Combustible Products, from 2016 
until 2018, this category reported a CAGR of -0.8%, which was caused by the decrease of 
cigarettes’ shipment volume of 8.9%. On the other hand, RRP’s units shipped, during the same 







Regarding the operating expenses, the company divides them into three principal 
components, which are Cost of Sales; Marketing, Administration and Research; and 
Amortization of Intangible. 
Exhibit 8 – Net sales per geographical segment  


























Combustible Products Reduced-Risk Products Total Sales %
Exhibit 9 – Net sales per product segment 
Source: PMI Annual Reports 
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From 2015 to 2018, the cost of sales of PMI registered a CAGR of 4.3%. This 
considerable increase is correlated with the same upward trend of Net Sales, which reported an 
equal CAGR. The tobacco company includes in this cost section expenses such as tobacco leaf 
and non-tobacco raw materials, labor and manufacturing costs and shipping and handling costs. 
The cost of sales is the main segment within the total operational expenses, weighting 75.9% 
(footnote 2018), as can be seen in Exhibit 10. 
 Moving to Marketing, Administration and Research, this section includes the cost of 
marketing, the cost of selling the products and the investments applied in the creation of new 
products. Over the past years, it reported a CAGR of 3.6%, which was driven by an increase in 
investments to create new products. Due to that rise, its weight on total operating expenses 
increased to 25%, at the end of 2018. 
Regarding the last component, Amortization of Intangible, due to its irrelevance - since 
it represents less than 0.3% of total operating expenses - it will be included directly in the 




Capital Expenditure  
Regarding the Capex, PMI does not segment this measure, it only reports the total. As 
Exhibit 11 reveals, between 2015 and 2017, Capex recorded a CAGR of 61%, which is mainly 
driven by the investments allocated to the production and development of RRPs. Due to a shift 
in PMI’s strategy, the company had to support capacity expansion, mainly for heated tobacco 
units. Nevertheless, after this initial investment, PMI was able to decrease its Capex expenses 
in 2018 by 7% and until September 2019 the firm reported a YoY of -36.8%, which lead to a 
decrease of this expenses over Net Revenues 
Exhibit 10 – Operational Expenses and Operating Margin 
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EBITDA & EBITDA Margin 
It is a fact that PMI’s EBITDA increased between 2016 and 2018, nevertheless, 
operational costs reported a higher CAGR - 4.3% vs 3.4% -, which led to a decrease of the 


























Exhibit 12 – EBITDA & EBITDA margin 
Source: PMI respective annual reports 
Exhibit 11 – Capital Expenses 
Source: PMI respective annual reports 





- 34 - 
Operating Income, EBT and Net Income 
Just like EBITDA, between 2016 and 2018, EBIT EBT and Net Income reported 
positive CAGR. However, the costs stated before also induced a decline in both, the EBIT 
margin and EBT margin. In 2016, the EBT margin reported an unusually low value, due to an 




Depreciation and Amortization 
Commonly, depreciation and amortization are connected with the value of Net Property, 
Plant and Equipment of the previous. As one can observe through the Exhibit below, D&A has 
been reporting a fairly constant percentage of Net Property, Plant and Equipment. It is also 
















Depreciation Amortization % Net property and Plant
Exhibit 14 – Depreciation & Amortization 
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Exhibit 13 – Operating Income, EBT and Net Income 
Source: PMI respective annual reports 
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Working Capital 
In this section, 2019 final year estimates are equal to the ones reported by PMI, by the 
end of the third quarter. The underlying assumption was assumed since considering the previous 
year’s results, there are no significant differences between the ones reported by the end of the 
third quarter and the ones record in the end of the underlying year. 
 Regarding the WC, PMI reports, by far, Inventory and Accrued Liabilities12 as the major 
components. Since this is a manufacturer company, traditionally Inventory assumes a greater 
position within the Working Capital. Moving to the second component mentioned, the main 
items identified as Accrued Liabilities are Taxes and Dividend Payable. As previously stated, 
PMI, as a tobacco company, is obliged to pay a great amount of excise taxes, which, 
consequently, will assume a greater concern in the Working Capital. Further, since the firm 
pays a considerable amount of dividends, the WC will also be deeply affected by that. Finally, 
it is also pertinent to note that the Net Working Capital does not suffer considerable changes 
YoY and it has been consistently assuming positive values, which, generally speaking, means 








12 Within this measure PMI includes Marketing and Selling, Taxes (excluding income taxes), Employment costs, 
Dividends Payable and Other. 
Exhibit 15 – Working Capital 
Source: PMI respective annual reports 
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4. Valuation 
After discussing and analyzing PMI’s past performance, as well, as the main growth drivers, 
one can already project the future of the tobacco company. First, one will start by explaining 
the reasoning behind the explicit period selection. Then, the revenues and operational forecast 
will be discussed, followed by the WACC and DCF valuation. Additionally, as a 
complementary method, the Multiple Valuation will be executed, and lastly, a sensitivity 
analysis will be performed and subsequently commented upon its overall results. 
 
Explicit Period 
As mentioned previously, PMI is facing the biggest strategic change in its existence. 
Their ultimate goal is to eliminate cigarettes and give greater importance to Reduced-Risk 
Products. The tobacco company indeed wants to complete this transition as soon as possible, 
nevertheless, PMI does not disclose any kind of forecast or target regarding this cigarette 
reduction. As much as the firm wants to reduce it, PMI would never do it at a pace that would 
mean reporting a revenue decline by the end of the year. Therefore, this expected slow pace 
reduction will be influenced by customers’ demand for both cigarettes and heated-tobacco 
products. Having this in mind, and since 2019 projected CF is not included in the valuation, the 
projections will be executed until 2029. In addition, composing a projection longer than that 
would come along with high uncertainty levels. 
 
Revenues 
 Since 2016, PMI changed dramatically its strategy, by focusing primarily on Reduced-
Risk Products and eliminating cigarettes from its portfolio. Thus, this setting will have a major 
impact on Net Revenues projections. In addition to the new strategic plan, the average industry 
growth, as well as, product growth was also a major driver for the Net Revenues estimation. By 
gathering all this information, in addition to PMI’s past performance, the company is expected 













Furthermore, regarding the currency effect, its influence in this projection is assumed as zero, 
for simplicity principles. PMI operates in 180 different markets, which can be translated into a 
wide range of different currencies. Thus, developing any kind of assumptions would come 
along with a severe bias risk, either upwards or downwards. 
 In this dissertation one opted to project Net Revenues based on a product division, 
mainly due to the new strategy. On a geographical basis PMI do not disclosers any kind of 
target or intention, and some regions do not report a clear pattern, which would lead to an 
uncertain estimation. Whereas, on a product level, the company has a clear objective, decrease 
the combustible products segment and focus on the RRP’s segment. Thus, one selected this 
path since it has a lower level of uncertainty than the previous one. 
Product Division 
As stated previously, to estimate 2019 Net Revenues, one annualized the results until 
September, to main the reported patterns. 
 By analyzing, on a product division basis, the Net Revenues’ trend of the last four years, 
one can already observe the effects of this new plan. Starting with Combustible Products 
category, this section has been decreasing since 2016, reporting a CAGR of -2.12%, from that 
year until 2019. These results walk closely with PMI’s primary objectives, reducing cigarette 
offer. Then, when moving to the other category - Reduced Risk Products -, the patterns shift 
completely. Since 2016, when it started to become separated from the rest, RRP’s reported an 
enormous CAGR of 64.7%. Once again, this growth goes in line with PMI objectives, of 
increase significantly RRP’s Net Revenues over Total Net Revenues. 
 PMI does not disclose any information regarding its long-term targeted cigarette 
reduction. Having that said, to project the Net Sales of Combustible Products, one will assume 
Exhibit 16 – Net Sales forecast 
Source: PMI’s 2019 Q3 and own estimation 
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the reduction reported since the strategy was implemented until 2019, as the main foundation. 
Thus, by analyzing the reported that since strategic shift, one can observe that between 2016 
and 2019, Net Revenues reported a CAGR of - 2.12% 
Also, note that as much as the company wants to reduce the cigarette offer, the decrease 
needs to be entirely offset by RRP’s increase, otherwise Net Revenues would decrease. Thus, 
based on the assumption that the company wants to perform this change, at least, without 
downgrading its Net Revenues amount, and to incorporate a conservative approach, one 
assumed that this decrease would be slowly and gradually executed. 
Thus, to estimate the Net Revenues concerning the combustible products segment, one 
will assume a similar CAGR already registered since the of the new strategy. This means, from 





Moving to the other category, Reduced-Risk Products, the expectations are completely distinct. 
The heat-not-burn tobacco is the major product within this category, thus it will be the major 
growth driver. Between 2019 and 2025, this product is expected to report a CAGR of 19.3%, 
as discussed previously on the Industry Overview. Instead of applying directly the same growth 
each year, to be more accurate, one will assume a decreasing growth. This means, the growth 
rate will be higher in the first years comparing to the last ones. Based on that, and 2019 YoY 
growth - 31% -, one expects that this category will report a 2020 YoY of 25%, with a decrease 
of 2.5 percentage points each year, until 2025 – 2025 YoY expected to be 12.5%. This would 
represent a CAGR of 18.7%, from 2019 to 2025, which goes in line with the expected product 
growth already mentioned. In order to maintain the consistency of the previous assumptions, 
one will expect a continuous decrease of 2.5 percentage points each year of YoY growth until 
Exhibit 17 – Combustible Products Net Sales projections 
Source: PMI’s 2019 Q3 and own estimation 
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2029 -2029 YoY expected to be 2.5%. Thus, by gathering all these assumptions, RRP’s segment 




By gathering these two segment projections, Net Revenues is expected to report a CAGR of 
2.7%, between 2019 and 2029. 
 
As Exhibit 19 demonstrates, according to the previous assumptions, by 2029 half of the 
PMI revenue source will come from Reduce-Risk Products. From this period onwards, one 




Operational Expenses  
As previously mentioned, the company divides its operational expenses into three 
sections. Nevertheless, due to the Intangible Assets irrelevance compared to the other two, this 
section will be included in Depreciation & Amortization.   
PMI does not disclose the proportion of each section on a geographical level, thus the 
projection will be made on a consolidated basis. Furthermore, just as it was done in Net 
Revenues, to predict 2019 operational expenses, one annualized the costs reported until the end 




2019E 2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E 2028E 2029E
Total Sales % Total Sales %
Exhibit 19 – Contribution of each segment to total Net Sales 
Source: PMI’s 2019 Q3 and own estimation 
 
Source: Thomson Reuters EIKON 
 
Exhibit 18 – RRP’s Net Sales projections 
Source: PMI’s 2019 Q3 and own estimation 
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Regarding the Cost of Sales, this section reported quite constant values over Net 
Revenues. Tobacco leaf and non-tobacco raw materials, labor and manufacturing costs are the 
main drivers of this section. Both labor and manufacturing costs are expected to remain the 
same. Nevertheless, due to new strategy tobacco leaf is expected to decrease, which is offset 
by the expected increase regarding the non-tobacco raw material costs. Thus, from 2020 on, 
this section will be assumed as the ratio of sales. More precisely, an average of the five years 
before 2020 - incorporates all the year since the strategy changed -,which is 35.6% of Net Sales. 
On the other hand, due to higher investments in RRP’s, Marketing, Administration and 
research costs have increased its ratio over Net Revenues. Since PMI wants to keep developing 
and advertising these new products, one expects this ratio to keep reporting similar percentages 
to the years in which the costs increased. Thus, this section’s values will be assumed as an 







 Regarding the EBITDA calculation, according to the assumptions previously 
considered, PMI will report a quite constant EBITDA margin of 42%. 
 
Exhibit 20 – Operational Expenses projections 
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Capital Expenditures 
Once again, to forecast the capital expenditures in 2019, the costs at the end of 
September were annualized. The company does not disclose how much is allocated to tangible 
assets or intangible assets. Thus, this measure will also be projected having Net Revenues as 
its driver. Due to PMI’s changing strategy, the company had to raise its investments on heated 
tobacco unit production capacity expansion, which increased the ratio Capex over Net 
Revenues. Nevertheless, after this intensive investment, in 2019 the company was already able 
to decrease this ratio to 4%. Thus, since the company will continue to give greater importance 
to the heated tobacco products, during the forecast period, capital expenses will be projected as 





Depreciation and Amortization 
Since Amortizations represent a very small portion of total D&A, there is no added value on 
forecasting this measure with Depreciation and Amortization separately. As mentioned in the 
previous chapter there is, commonly, an intrinsic relation between the measure in question and 
PP&E of the previous year. Thus, D&A will be forecasted as the average ratio of D&A over 
Net PP&E, of the last five years, which represents 14.3% of the Net PP&En-1. From 2019 
onwards, one assumed that the value of Net PP&E would increase at the same pace as sales 
growth. Thus, since Capex also has Net Revenues as its main driver, both Capex and Net PP&E 
will always follow the same patterns. In addition, since D&A is projected as a % of Net PP&E, 
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Exhibit 21 Capital Expenses projections 
Source: PMI’s 2019 Q3 and own estimation 
 
 










Regarding the Working Capital requirements, other than the traditional categories - 
Receivables, Inventory and Payables -, PMI also includes Accrued Liabilities, Other Assets and 
Income Taxes. As previously mentioned, the 2019 final results were forecasted according to 
reported until September.  
 Starting with receivables, this measure has recorded similar DSO13 over the last year. 
Thus, to projected it, an average DSO of the last three years will be assumed - 46 days. In 
addition, both inventory and payables reported similar patterns. Therefore, once again, 
inventory will be assumed as an average DSI14 of the last three years - 177 days - and payables 
will be projected as an average DPO15 of the last three years - 41 days. Moving to Accrued 
Liabilities, within this measure, PMI includes Marketing and Selling, Taxes (excluding income 
taxes), Employment costs, Dividends Payable and Other (PMI do not discriminate what is 
included). In order to predict, due to its stable ratio over Net Revenues, from 2020 on, Accrued 
Liabilities will be assumed as 33.9% of Net Sales. Moreover, both Other current assets and 
Income Taxes, were also estimated as the average ratio over Net Sales of the last three years. 
More specifically, the first one was projected as 2.1% and the second as 2.4% of the Net 
Revenues.  
 Also, in order to compute the Net Deferred Income Tax, one will use the Net Revenues 
as main driver. Regarding the measure of Deferred Income Tax Assets, the company as reported 
constant values. For that reason, this item will be projected as an average % of sales between 
2015 and 2018, which corresponds to 3.8% of Net Revenues. On the other hand, the Deferred 
Income tax liabilities suffered a considerable reduction between 2016 and 2017, due to 
 
13 DSO – on average, how many days it takes a company to receive the payments after selling the products   
14 DSI – on average, how many days it takes a company to turn its inventory into sales 
15 DPO – on average, how many days it takes a company to pay its liabilities to trade creditors 
Exhibit 22– D&A projections 
Source: PMI’s 2019 Q3 and own estimation 
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Unremitted Earnings and Foreign Exchange. Thus, one will assume this measure as a % of Net 




Free-Cash Flow to the Firm 
After projecting all the necessary inputs for the FCF calculation, in this section, one will 
present its calculation. The method applied was the one stated in the literature review, as 
appendix 8 reveal. The overall results demonstrate a constant YoY growth of 2.7%, from 







In order to compute the appropriate discount rate - weighted average cost of Capital -, 
the method mentioned in the literature review was applied. After gathering and forecasting all 
inputs needed (discussed below), the result was 7,2%. 
 
Exhibit 24 – FCFF projections 
Source: PMI respective annual reports and own calculations 
Exhibit 23 – Working Capital Projections 
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Capital Structure  
 One of the most critical components of the WACC calculation is the capital structure 
assumption. In order to compute the Equity Value of PMI, one multiplied the total number of 
shares outstanding - 1556M - with the price per share - $84.316 -, which resulted in a value of 
$131.1B. Regarding the Market Value of debt, only traded debt was included in the calculation, 
thus, only traded bonds,  since  PMI does not have loans. To compute the market value of the 
traded bonds, the price2 of each one was multiplied by the correspondent outstanding amount, 
which represents a total of $32.6B. Thus, PMI’s Debt to Equity ratio is 0,25. PMI capital 
structure has remained constant over the last year, and there no indication concerning a capital 
structure change for the upcoming year (see appendix 1). 
Cost of Equity 
Regarding the discount rate required by equity holders, to reach that value the CAPM 
Model was implemented. Considering all the inputs calculated below the cost of equity is 
8,57%. 
Risk-free 
Since Philip Morris is an American company and its official currency is the US Dollar 
($), as mentioned previously in the literature review, the best proxy for the risk-free considering 
these conditions is the YTM of a 10-year’s zero-coupon American Bond. In this case, it was 
used a bond issued on 12th of December of 2019, with a rate of 1.79%17. 
 
 
16 Thomson Reuters EIKON, 12th December 2019 
17 Source: Treasury American Government, 12th December 2019 




Beta Unlevered   
Beta Levered 0.81 
Tax rate 22.55% 
Market Risk Premium 8.38% 
Ke 8.57% 
Cost of Debt 
Kd 1.97% 
Kd (1-t) 1.53% 
WACC 7.2% 
Exhibit 25 – WACC 
Source: Bloomberg and PMI annual reports 
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Beta 
In order to estimate PMI’s beta, the method mentioned in the literature review was 
applied. Before running the regression, one gathered weakly data from the last 5 years, of both 
PMI and S&P 500 stock price. After executing the regression, its outcome returned a raw beta 
of 0,73. Then, the Bloomberg smoothing method was applied, and the final value of the levered 
beta was 0,81. 
Market Risk premium 
Regarding the expected market risk premium, to calculate this measure, one used a 
weighted-average process. Meaning, extracted from Bloomberg, one gathered the expected risk 
premium of all regions where Philip Morris operates. Then, to achieve a more accurate value, 
those values where weighted-average, accordingly with the revenues amount of each region. 
After executing all these steps, a Market Risk Premium of 8.4% was achieved (see appendix 
2). 
Cost of Debt (tax rate) 
In order to compute the rate of return required by debtholders, one executed a weighted 
average YTM of the treated Bond. As stated in the literature review, commonly, when a 
company has traded debt, the yield-to-maturity of that debt is the best proxy for the company’s 
cost of debt. After being extracted, all these YTM’s were weighed-averaged accordingly with 
the correspondent market value of the underlying bond, which resulted in a cost of debt of 
1.97% (see appendix 3). 
Regarding the effective tax rate, one will assume a rate of 22.5%18, which is precisely 
the average between 2018 and 2019 until September. The reasoning behind it is the fact that, 
those years are the only ones already update with the most recent US federal statutory rate, 





18 Source: PMI’s 2019 Q3 
 2016 2017 2018 2019 Q3 
Effective Tax  27.90% 40.70% 22.90% 22.20% 
Exhibit 26 – Effective Tax Evolution 
Source: PMI respective annual reports 
Source: Thomson Reuters EIKON 
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Terminal Value (Terminal Growth Rate) 
 In order to fulfill all the inputs necessary to compute the Terminal Value, the terminal 
growth rate still needs to be estimated. The current worldwide GDP annual growth – driver for 
g - is 3%19. Nevertheless, the long-term growth of the tobacco industry is expected to be 
negatively affected by several trends, such as tobacco prevalence decrease, the world’s growing 
awareness of the negative effects of tobacco, etc. Thus, since a terminal growth rate higher then 
2% is unrealistically high and considering all due those negative influences just mentioned, one 
will assume a conservative approach, by expecting half of that rate – 1%. Having that said, the 
expected discounted terminal value is $94B, which represents 60% of the total valuation.  
 
Discount Cash Flow Valuation 
 After prosecuting the steps need to reach PMI valuation, one is already able to execute 
it. According to all the projections mentioned before, PMI’s total value is $165B, which is 
proclaimed by two main holders. The firm’s market value of debt is $32.6B, deducting Cash 
and Cash Equivalents, one reaches a Net Debt of 26.1B. In order to calculate PMI’s Equity 
Value, one needs to subtract the Net Debt and the minority interest, over the total value. Thus, 










 After performing a certain valuation, it is crucial to execute a sensitivity analysis, to 
understand the impact of smaller deviations on the inputs assumed – WACC, terminal growth 
rate, etc.).           
 
19 The World Bank 
Enterprise Value 164678 




Equity Value 138240 
Number of shares 1556 
Price per Share $88.9 
Exhibit 27 – Enterprise Value, Equity Value and Price per Share 
Source: Own calculations 
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 Since 60% of PMI valuation derives from the Terminal Value, in this first analysis, one 
will evaluate the impact of smaller changes of both WACC and Terminal Growth Rate, 
considering that all the other assumptions remain constant. In addition, the sensitivity of the 
share price regarding the inputs just mentioned will also be tested. If there is a decrease of 50 
percentage points in the WACC and an increase of that amount on the Terminal Growth Rate, 
PMI’s Terminal Value and price per share rise almost 20% and 14%, respectfully. Whereas, if 
the complete opposite occurs, the Terminal Value decreases 14% and share price declines 11%. 
These results demonstrate that both TV and share price are very sensitive to changes in WACC 
and Terminal Growth Rate. It is also pertinent to note that, measures tested, are more sensitive 



















Hence, there still some conditions that can still deeply affect the revenues, and 
consequently the share price, such as, inflation and foreign exchange. Furthermore, the 
operating margin is also one of the most crucial measures for the final valuation result. Thus, 
in order to evaluate the impact of these variables, one executed four distinct scenarios, as 
Exhibit 28 illustrates.  
 














88.9 6.57% 6.87% 7.17% 7.47% 7.97% 
0.00% 89.2 84.4 80.0 75.9 69.8 
0.50% 94.4 89.0 84.1 79.6 72.9 
1.00% 100.5 94.4 88.9 83.8 76.4 
1.50% 107.8 100.8 94.5 88.8 80.5 
2.00% 116.8 108.5 101.2 94.7 85.3 






187016 0.00% 0.50% 1.00% 1.50% 2.00% 
6.17% 185165 202492 223170 248273 279391 
6.67% 171290 186091 203500 224275 249496 
7.17% 159350 172147 187016 204507 225380 
7.67% 148966 160147 173003 187942 205515 
8.17% 139852 149711 160943 173859 188868 
Exhibit 28 – Sensitivity Analyses of Terminal Value and Price per Share 
Source: Own calculations 













One the first scenario, which is the most optimistic one, PMI’s stock price would increase by 
almost 28% over the target price mentioned in the DCF valuation. Considering the second 
scenario, within the optimistic setting, the stock price would rise by 13%. Whereas, if one 
considers the most pessimist overview, the price would decline by 23%. 
 
Relative Valuation 
In this section, on a complementary side, a relative valuation will be performed. 
Regarding this method specifically, the quality of the overall outcome is highly dependable on 
the peer group selected. Thus, to obtain a result with higher consistency and reliance, one 
gathered two distinct groups. The multiples selected were P/E, P/Revenues and EV/EBITDA, 
which includes both Equity and Enterprise multiples. The first two were mainly chosen since 
ultimately, they are based on the shareholders’ value – the main question of this dissertation -, 
whereas EV/EBITDA was selected, to include a multiple focused on the operational 
performance of the company. 
The first one only contains firms operating in the tobacco industry and were selected 
based on the following criteria: global presence, net revenues and market capitalization of a 
similar size to those of PMI. 
 
Tobacco Peer Group P/E  EV/EBITDA P/Net Revenue 
Altria Group Inc 54.21 11.49 3.72 
British American Tobacco PLC 11.27 10.12 2.71 
Japan Tobacco Inc 12.05 8.27 2.30 
Philip Morris International Inc 17.42 12.94 4.41 
Harmonic Average 15.78 9.78 2.79 
       




  Revenue Growth OPEX Margin Share Price 
Optimistic 
2% 2% $110.8 
1% 1% $98.1 
Pessimist 
-1% -1% $76.2 
-2% -2% $66.8 
Exhibit 29 – Sensitivity Analyses of Price per Share 
Source: Own calculations 
Source: Thomson Reuters EIKON 
 
Exhibit 30 – Tobacco Peer Group 
Source: Thomson Reuters EIKON 12/12/2019 
Source: Thomson Reuters EIKON 
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 Based on those requirements, only three companies were selected, Altria and BAT, both 
from US, and Japan Tobacco. As one can observe from the Table above, regarding the last two 
multiples, the market perceives PMI share as overvalued, since they are being traded at price 
over the one the market perceives as fair. Meaning, according to the market, for the size that 
PMI possesses and for the current price per share, the company should report superior EBITDA 
and Net Revenues, respectfully. On the other hand, regarding the multiple P/E, PMI shares are 
being traded at a fair value, still according to market perception. 
Due to the limited number of tobacco companies similar to PMI present in the market, 
one felt the need to execute this method with a second and wider peer group. Thus, the peer 
group elected by PMI was the chosen one for the valuation process. Every year, the tobacco 
company has been reporting its own peer group, which is based on the following requirements: 
global presence, net revenues, focus on consumer products and market capitalization of a 
similar size to those of PMI. By spreading the scope across different industries, the number of 









This time, the market perceives PMI shares as overvalued in the last multiple, whereas, 
based on the multiple EV/EBITDA, PMI stock is being fairly traded. Nevertheless, regarding 
the first multiple, the stocks are being traded at a higher than it should. From a general 
perspective, this second analyzes returns values closer to PMI’s actual price.  
All in all, the relative valuation reports distinct signals depending on the peer group, 
and on the multiple itself. Nevertheless, this method is commonly used only as a 
complementary approach, with the objective of getting a sense of how the market values these 
firms, and not as a primary source for an investment decision. 
 
Philip Morris International Inc 17.42 12.94 4.41 
Harmonic Average 19.65 13.09 3.16 
        
Price per Share $109.51 $87.49 $60.17 
Exhibit 31 – PMI Peer Group 
Source: Thomson Reuters EIKON 12/12/2019 
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5. Comparison with Investment Bank 
 The objective of this chapter is to compare the valuation executed in this dissertation 
with one performed by an Investment Bank. In this case, the valuation developed will be 
compared with the one produced by Barclays on 19th November of 2019. 
 Based on a Multiple Valuation, Barclays considers a target of $100, which symbolized 
a potential upside of 18%, on the day the recommendation was realized. This target priced is 
based on a projected 2020 P/E of 15.4. 
 One of the principal reasons for the difference between this dissertation target price and 
Barclays’s is the fact that both values were estimated based on distinct valuation models. The 
DCF model considers, by far, many more assumptions, which can deviate the target price. In 
addition, both methods assume very different explicit periods, which also influences the target 
price. 
 Although the target price is based on a multiple valuation, Barclays also estimates PMI 
results until 2021, which can give a sense of some assumptions considers by the investment 
bank. Regarding sales, there is a considerable difference between the two valuations, mostly 
because Barclays considers a slower pace regarding cigarette reduction and predicts higher Net 








By the EBITDA margin reported by Barclays, one can conclude that the investment bank 
assumes higher saving costs then the ones assumed in this dissertation. Barclays does not 








Revenue 2019E 2020E 2021E CAGR 
Barclays 30277 31864 33717 5.5% 
Disseration 29734 30568 31581 3.1% 
EBITDA Margin 2019E 2020E 2021E Average 
Barclays 41.9% 42.5% 43.1% 42.5% 
Disseration 39.7% 42.1% 42.1% 42.1% 
Exhibit 32 – Net Revenues comparison 
Source: Barclays data and own calculations 
Source: Thomson Reuters EIKON 
 
Exhibit 33 – EBITDA margin comparison 
Source: Barclays data and own calculations 
Source: Thomson Reuters EIKON 
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Regarding both Capex and D&A, Barclays estimated similar values to those projected in this 










After analyzing both estimations, one can conclude that the difference between the estimated 
target price – $100 vs $88.9 - relays on Net Revenues assumptions. Barclays assumes a more 

















D&A 2019 2020 2021 
Barclays 987 1036 1096 
Disseration 1000 1031 1060 
Capex  2019 2020 2021 
Barclays 999 1243 1248 
Disseration 1189 1223 1263 
Exhibit 34 – D&A and Capex comparison 
Source: Barclays data and own calculations 
Source: Thomson Reuters EIKON 
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6. Conclusion 
 This dissertation was developed under the intention of performing an equity research 
valuation on a company trading in the stock market, more precisely, Philip Morris International.  
 In addition to that, an analysis of the tobacco market was also executed. Considering 
that matter, this industry is suffering considerable changes due to the decrease of tobacco 
prevalence, as well as, the world’s growing awareness of the negative effects of tobacco. Due 
to that, RRP’s are expected to become the main consumed option within the industry, on a long-
term horizon. 
 As stated before, every valuation technique is characterized by both down and upsides. 
Moreover, putting that together with PMI characteristics, the DCF-model was the elected one 
to conduct the valuation. Considering the selected assumptions, the DCF-model projected an 
Equity Value of $138B, which corresponds to a price per share of $88.9. PMI is considered to 
be slightly undervalued by the market since on 3rd of January of 2020 the price was trading at 







































































































Book Value 2016 2017 2018 2019 
Debt 29067 34339 31759 31800 
Equity 24212 22842 23296 22802 
Assets 36851 42968 39801 41420 
D/E 54.6% 60.1% 57.7% 58.2% 
     
Credit Rating 2016 2017 2018 2019 
S&P A A A A 
Moody's A2 A2 A2 A2 
  Market Premium % 
European Union 9.65% 33.41% 
Eastern Europe 7.19% 10.41% 
Middle East & Africa 6.54% 13.84% 
South & Southeast Asia 8.48% 16.33% 
East Asia & Australia 8.76% 18.53% 
Latin America & Canada 6.56% 7.48% 
PMI MP 8.38% 
SUMMARY OUTPUT        
         
Regression Statistics        
Multiple R 0.408        
R Square 0.167        
Adjusted R 
Square 
0.163        
Standard Error 0.029        
Observations 260        
 
        
ANOVA    
  df SS MS F Significance F    
Regression 1 0.044 0.044 51.622 0.000    
Residual 258 0.221 0.001        
Total 259 0.265          
 










Intercept -0.001 0.002 -0.506 0.613 -0.005 0.003 -0.005 0.003 
X Variable 1 0.728 0.101 7.185 0.000 0.528 0.928 0.528 0.928 
Appendix 2 – Market Risk Premium 
Source: Bloomberg 05/12/2019 
Source: Thomson Reuters EIKON 
 
Appendix 1 – Book Value of Equity & Debt and Credit Rating 
Source: PMI respective Annual Reports 
Source: Thomson Reuters EIKON 
 
Appendix 2 – Beta 
Source: Thomson Reuters Eikon (05/12/2019) and own calculations 
Source: Thomson Reuters EIKON 
 













Outstanding Coupon Yield YTM Last Price  Market Value % 
21-Feb-2020 1,000,000,000 2.00 1.96 2.06 100.01 1.000061 1,000,061,000 3.07% 
21-Feb-2020 300,000,000 2.31 1.89 1.89 100.09 1.000908 300,272,400 0.92% 
19-Mar-2020 1,384,500,000 1.75 -0.14 -0.15 100.52 1.00523 1,391,740,935 4.27% 
26-Mar-2020 1,000,000,000 4.50 1.98 2.00 100.76 1.007602 1,007,602,000 3.09% 
18-Sep-2020 328814245 1.00 -0.59 -0.59 101.24 1.01239 332,888,253 1.02% 
25-Feb-2021 750000000 1.88 1.93 1.93 99.93 0.999339 749,504,250 2.30% 
03-Mar-2021 830700000 1.88 -0.01 -0.01 102.32 1.02323 849,997,161 2.61% 
17-May-2021 350000000 4.13 1.99 2.00 103.03 1.030314 360,609,900 1.11% 
15-Nov-2021 750000000 2.90 1.86 1.98 101.97 1.019728 764,796,000 2.35% 
06-Dec-2021 303520842 2.00 -0.24 -0.27 104.47 1.04468 317,082,153 0.97% 
18-Feb-2022 500000000 2.63 2.05 2.06 101.23 1.012273 506,136,500 1.55% 
17-Aug-2022 750000000 2.38 2.09 2.09 100.75 1.007499 755,624,250 2.32% 
22-Aug-2022 750000000 2.50 2.06 2.10 101.15 1.011548 758,661,000 2.33% 
02-Nov-2022 750000000 2.50 2.02 2.07 101.36 1.013564 760,173,000 2.33% 
06-Mar-2023 600000000 2.63 2.14 2.17 101.52 1.015224 609,134,400 1.87% 
10-May-2023 500000000 2.13 2.08 2.12 100.16 1.001569 500,784,500 1.54% 
15-Nov-2023 500000000 3.60 2.16 2.20 105.40 1.053994 526,997,000 1.62% 
01-May-2024 900000000 2.88 2.18 2.17 102.88 1.028839 925,955,100 2.84% 
16-May-2024 252934035 1.63 0.07 0.12 106.89 1.06893 270,368,778 0.83% 
30-May-2024 664560000 2.88 0.24 0.29 111.70 1.11703 742,333,457 2.28% 
08-Nov-2024 553800000 0.63 0.45 0.04 100.84 1.00839 558,446,382 1.71% 
10-Nov-2024 750000000 3.25 2.20 2.22 104.89 1.048945 786,708,750 2.42% 
19-Mar-2025 830700000 2.75 0.50 0.45 111.66 1.11663 927,584,541 2.85% 
11-Aug-2025 750000000 3.38 2.33 2.32 105.54 1.055442 791,581,500 2.43% 
25-Feb-2026 750000000 2.75 2.49 2.44 101.48 1.014821 761,115,750 2.34% 
03-Mar-2026 1107600000 2.88 0.59 0.53 113.95 1.13945 1,262,054,820 3.87% 
03-Aug-2026 553800000 0.13 0.68 0.60 96.42 0.9642 533,973,960 1.64% 
17-Aug-2027 500000000 3.13 2.54 2.55 104.03 1.040341 520,170,500 1.60% 
02-Mar-2028 500000000 3.13 2.72 2.72 102.96 1.029596 514,798,000 1.58% 
14-May-2029 553800000 2.88 1.05 1.00 116.32 1.16324 644,202,312 1.98% 
15-Aug-2029 750000000 3.38 2.80 2.77 104.82 1.048194 786,145,500 2.41% 
01-Aug-2031 830700000 0.80 1.34 1.28 94.19 0.94194 782,469,558 2.40% 
03-Jun-2033 553800000 3.13 1.51 1.47 119.60 1.19602 662,355,876 2.03% 
09-May-2036 553800000 2.00 1.59 1.56 105.89 1.05888 586,407,744 1.80% 
06-Nov-2037 553800000 1.88 1.76 1.73 101.78 1.01784 563,679,792 1.73% 
16-May-2038 1500000000 6.38 3.55 3.44 137.93 1.379332 2,068,998,000 6.35% 
01-Aug-2039 830700000 1.45 2.00 1.93 91.13 0.91132 757,033,524 2.32% 
15-Nov-2041 750000000 4.38 3.56 3.55 112.27 1.122738 842,053,500 2.59% 
20-Mar-2042 700000000 4.50 3.68 3.62 112.46 1.124641 787,248,700 2.42% 
21-Aug-2042 750000000 3.88 3.53 3.55 105.29 1.052896 789,672,000 2.42% 
04-Mar-2043 850000000 4.13 3.56 3.50 108.96 1.089604 926,163,400 2.84% 
15-Nov-2043 750000000 4.88 3.68 3.59 118.89 1.188945 891,708,750 2.74% 
10-Nov-2044 1,250,000,000 4.25 3.53 3.52 111.84 1.118372 1,397,965,000 4.29% 
- 30,637,529,122 - - -- - -- 32,573,259,897 100.00% 
              WA 1.97 
Appendix 3 – Cost of Debt 
Source: Thomson Reuters Eikon 12/12/2019 
Source: Thomson Reuters EIKON 
 























Income Statment 2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E 2028E 2029E 
Total Revenue 28,748  29,625  29,734  30,568  31,581  32,739  33,991  35,266  36,478  37,532  38,332  38,789  38,831  
Operating Expenses (17,167) (18,248) (18,933) (18,737) (19,358) (19,995) (20,759) (21,538) (22,361) (23,007) (23,497) (23,777) (23,803) 
Cost of Sales 10,432  10,758  10,411  10,867  11,227  11,639  12,084  12,538  12,968  13,343  13,628  13,790  13,805  
Marketing, Admnistration and 
Research 
6,647  7,408  8,522  7,870  8,131  8,355  8,675  9,000  9,393  9,664  9,870  9,987  9,998  
Amortization of Intagible 88  82  - - - - - - - - - - - 
Op. Income 11,581  11,377  10,801  11,830  12,222  12,745  13,232  13,728  14,117  14,525  14,834  15,011  15,028  
EBIT % 40.3% 38.4% 36.3% 38.7% 38.7% 38.9% 38.9% 38.9% 38.7% 38.7% 38.7% 38.7% 38.7% 
Interest expenses (134) (159) (149) (153) (158) (164) (170) (177) (183) (188) (192) (194) (195) 
Pension and other employee 
benefit 
(78) (41) (73) (75) (78) (81) (84) (87) (90) (93) (94) (96) (96) 
EBT 11,369  11,177  10,579  11,601  11,986  12,500  12,978  13,464  13,844  14,244  14,548  14,721  14,737  
EBIT % 39.55% 37.73% 35.58% 37.95% 37.95% 38.18% 38.18% 38.18% 37.95% 37.95% 37.95% 37.95% 37.95% 
Provision for Income Taxes (4,307) (2,445) (2,349) (2,576) (2,661) (2,775) (2,881) (2,989) (3,073) (3,162) (3,230) (3,268) (3,272) 
Equity investments and 
securities (income)/loss, net 
(59) (60) (75) (77) (80) (83) (86) (89) (92) (95) (97) (98) (98) 
Non controlling (306) (375) (336) (345) (357) (370) (384) (399) (412) (424) (433) (438) (439) 
Net income 7,003  8,672  8,155  8,949  9,246  9,642  10,011  10,386  10,679  10,987  11,221  11,355  11,368  
Appendix 4 – Income statement 
Source: PMI respective annual reports and own calculations 
Source: Thomson Reuters EIKON 
 






















Balance Sheet 2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E 2028E 2029E 
Non-Current assets                           
Property and equipment  14,566 14,557 14,164 14,791 15,281 15,842 16,447 17,064 17,650 18,160 18,547 18,768 18,789 
     Land 639 600                       
     Buildings 3,989 3,975                       
     Machinery and Equipment 8,976 9,096                       
     Construction in Progress 962 886                       
Less accumulated D&A -7,295 -7,356 -7,528 -7,824 -8,083 -8,380 -8,700 -9,027 -9,337 -9,606 -9,811 -9,928 -9,939 
Goodwill  7,666 7,189 5,720 7,884 8,142 8,538 8,856 9,231 9,490 9,857 10,061 10,177 10,188 
Other intangible assets, net  2,432 2,278 2,088 2,568 2,650 2,844 2,944 2,997 3,144 3,304 3,368 3,405 3,408 
Investments in unconsolidated 
subsidiaries and equity 
securities  
1,074 1,269 4,499 1,306 1,346 1,424 1,443 1,615 1,614 1,656 1,688 1,749 1,751 
Deferred income taxes  1,007 977 968 1,096 1,131 1,170 1,213 1,306 1,380 1,416 1,443 1,459 1,464 
Total 19,450 18,914 19,911 19,821 20,467 21,437 22,203 23,186 23,942 24,787 25,296 25,631 25,662 
Current assets                           
Cash and cash equivalents 8,447 6,593 6,507 6,758 6,982 7,239 7,515 7,797 8,065 8,298 8,475 8,576 8,585 
Trade receivables  3,194 2,950 3,073 3,829 3,955 4,101 4,257 4,417 4,569 4,701 4,801 4,858 4,863 
Other receivables 544 614 656                     
Inventories 8,806 8,804 8,529 9,106 9,408 9,717 10,089 10,467 10,867 11,181 11,419 11,556 11,568 
Leaf tobacco  2,606 2,318                       
Other raw materials  1,563 1,405                       
Finished product  4,637 5,081                       
Other current assets  603 481 810 657 678 703 730 758 784 806 824 833 834 
Total 21,594 19,442 19,575 20,350 21,024 21,760 22,592 23,439 24,285 24,986 25,519 25,823 25,851 
Other Assets   1,445 1,934 1,940 2,092 2,063 2,284 2,307 2,376 2,436 2,481 2,507 2,510 
Total Assets 41,044 39,801 41,420 42,111 43,584 45,260 47,079 48,932 50,603 52,209 53,297 53,961 54,023 
Appendix 4 – Balance Sheet - Assest 
Source: PMI respective annual reports and own calculations 
Source: Thomson Reuters EIKON 
 




















  2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E 2028E 2029E 
Common stock, no par value  0 0 0 0 0 0 0 0 0 0 0 0 0 
Additional paid-in capital  1,972 1,939 1,981 1,981 1,981 1,981 1,981 1,981 1,981 1,981 1,981 1,981 1,981 
Earnings reinvested in the business  29,859 31,014 31,197 31,197 31,197 31,197 31,197 31,197 31,197 31,197 31,197 31,197 31,197 
Accumulated other comprehensive 
Losses 
-8,535 -10,111 -8,966 -9,825 -10,151 -10,523 -10,926 -11,335 -11,825 -12,089 -12,421 -12,567 -12,581 
Less: cost of repurchased stock  -35,382 -35,301 -35,222 -35,500 -35,500 -35,500 -35,500 -35,500 -35,500 -35,500 -35,500 -35,500 -35,500 
Non Controlling interest 1,856 1,720 1,855 1,901 1,964 2,036 2,114 2,193 2,269 2,334 2,384 2,412 2,415 
Total Equity -10,230 -10,739 -9,155 -10,246 -10,508 -10,809 -11,133 -11,464 -11,878 -12,077 -12,359 -12,477 -12,488 
Non-Current liabilities                           
Long Term Debt 31,334 26,975 26,426 27,500 28,411 29,454 30,580 31,727 32,817 33,765 34,485 34,896 34,934 
Deferred Income taxes 799 898 905 928 959 994 1,032 1,071 1,108 1,140 1,164 1,178 1,179 
Employment costs  2,271 3,083 2,859 3,060 3,162 3,278 3,403 3,530 3,652 3,757 3,837 3,883 3,887 
Income Taxes and other liabilities 2,832 2,393 2,340 2,437 2,518 2,611 2,710 2,812 2,909 2,993 3,056 3,093 3,096 
Total 37,236 33,349 32,530 33,926 35,050 36,337 37,726 39,141 40,486 41,655 42,543 43,050 43,097 
Current liabilities                           
Short-term borrowings  499 730 355 559 578 599 622 645 667 686 701 709 710 
Current portion of long-term debt  2,506 4,054 5,035 4,680 4,835 5,012 5,204 5,399 5,584 5,746 5,868 5,938 5,945 
Accounts payable 2,242 2,068 1,704 2,086 2,155 2,226 2,311 2,397 2,489 2,561 2,615 2,647 2,650 
Accured liabilities 9,903 9,763 10,228 10,373 10,717 11,110 11,535 11,967 12,379 12,736 13,008 13,163 13,177 
Marketing and selling  708 732 677                     
Taxes, except income taxes  5,324 5,088 5,130                     
Employment costs  856 794 813                     
Dividends payable  1,669 1,783 1,831                     
Other  1,346 1,366 1,777                     
Income Taxes 812 576 723 734 758 786 816 846 876 901 920 931 932 
Total 15,962 17,191 18,045 18,431 19,042 19,732 20,487 21,255 21,995 22,630 23,113 23,388 23,414 
Total Liabilities 53,198 50,540 50,575 52,357 54,092 56,069 58,213 60,396 62,480 64,286 65,656 66,438 66,511 
Total Shareholders equity & Liabilities 42,968 39,801 41,420 42,111 43,584 45,260 47,079 48,932 50,602 52,209 53,297 53,961 54,023 
Appendix 5 – Balance Sheet – Equity & Liabilities 
Source: PMI respective annual reports and own calculations 
Source: Thomson Reuters EIKON 
 














Working Capital 2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E 2028E 2029E 
Net Working Capital 398 521 602 594 614 609 632 656 709 730 745 754 755 
Investment (-) / 
Divestment (+) in 
WC 
(1,186) (123) (82) 8 (20) 5 (23) (24) (54) (20) (16) (9) (1) 
              
Recevables 3,738 3,564 3,729 3,829 3,955 4,101 4,257 4,417 4,569 4,701 4,801 4,858 4,863 
Trade Receivables 3,194 2,950 3,073                     
Other Receivables 544 614 656                     
DSO  47.5 43.9 45.8 45.7 45.7 45.7 45.7 45.7 45.7 45.7 45.7 45.7 45.7 
% of Sales 13.00% 12.03% 12.54% 12.52% 12.52% 12.52% 12.52% 12.52% 12.52% 12.52% 12.52% 12.52% 12.52% 
Inventories 8,806 8,804 8,529 9,106 9,408 9,717 10,089 10,467 10,867 11,181 11,419 11,556 11,568 
DIH 189 176 167 177 177 177 177 177 177 177 177 177 177 
% of Sales 30.63% 29.72% 28.68% 29.68% 29.68% 29.68% 29.68% 29.68% 29.68% 29.68% 29.68% 29.68% 29.68% 
Payables  2,242 2,068 1,704 2,086 2,155 2,226 2,311 2,397 2,489 2,561 2,615 2,647 2,650 
DPO 48 41 33 41 41 41 41 41 41 41 41 41 41 
% of Sales 7.80% 6.98% 5.73% 6.84% 6.84% 6.84% 6.84% 6.84% 6.84% 6.84% 6.84% 6.84% 6.84% 
Accured Liabilities 9,903 9,763 10,228 10,373 10,717 11,110 11,535 11,967 12,379 12,736 13,008 13,163 13,177 
% of Sales 34.45% 32.96% 34.40% 33.9% 33.9% 33.9% 33.9% 33.9% 33.9% 33.9% 33.9% 33.9% 33.9% 
Marketing and Selling 708 732 677                     
% of Sales 2.46% 2.47% 2.28%                     
Taxes, except income 
taxes 
5324 5088 5130                     
% of Sales 18.52% 17.17% 17.25%                     
Employement costs 856 794 813                     
% of Sales 2.98% 2.68% 2.73%                     
Dividends Payable 1669 1783 1831                     
% of Sales 5.81% 6.02% 6.16%                     
Other 1346 1366 1777                     
% of Sales 4.68% 4.61% 5.98%                     
Other current assets  603 481 810 657 678 703 730 758 784 806 824 833 834 
% of Sales 2.1% 1.6% 2.7% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 
Income Taxes 812 576 723 734 758 786 816 846 876 901 920 931 932 
% of Sales 2.8% 1.9% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 
Net Deferred Tax 
liabilities 
208 79 190 195 202 209 217 225 233 239 245 248 248 
Tax Assets 1026 1089 1120 1151 1189 1233 1280 1328 1374 1413 1443 1461 1462 
% of Sales 3.6% 3.7% 3.8% 3.8% 3.8% 3.8% 3.8% 3.8% 3.8% 3.8% 3.8% 3.8% 3.8% 
Tax Liabilities 818 1010 930 956 988 1024 1063 1103 1141 1174 1199 1213 1214 
% of Sales 2.8% 3.4% 3.1% 3.1% 3.1% 3.1% 3.1% 3.1% 3.1% 3.1% 3.1% 3.1% 3.1% 
  2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E 2028E 2029E 
Capex 1,548 1,436 1,189 1,223 1,263 1,310 1,360 1,411 1,459 1,501 1,533 1,552 1,553 
% of total sales 5.4% 4.8% 4.00% 4.00% 4.00% 4.00% 4.00% 4.00% 4.00% 4.00% 4.00% 4.00% 4.00% 
Appendix 6 – Working Capital  
Source: PMI respective annual reports and own calculations 
Source: Thomson Reuters EIKON 
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Source: PMI respective annual reports and own calculations 
 
 




















DCF-Valuation 2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E 2028E 2029E TV 
Revenues 28,748 29,625 29,734 30,568 31,581 32,739 33,991 35,266 36,478 37,532 38,332 38,789 38,831 - 
Growth (%) 7.7% 3.1% 0.4% 2.8% 3.3% 3.7% 3.8% 3.7% 3.4% 2.9% 2.1% 1.2% 0.1%   
OPEX (17,167) (18,248) (18,933) (18,737) (19,358) (19,995) (20,759) (21,538) (22,361) (23,007) (23,497) (23,777) (23,803)   
Operating Income 11,581 11,377 10,801 11,830 12,222 12,745 13,232 13,728 14,117 14,525 14,834 15,011 15,028 - 
Gross margin (%) 40.3% 38.4% 36.3% 38.7% 38.7% 38.9% 38.9% 38.9% 38.7% 38.7% 38.7% 38.7% 38.7%   
EBITDA 12,544 12,448 11,801 12,861 13,282 13,839 14,367 14,907 15,339 15,790 16,136 16,340 16,373 - 
EBITDA margin (%) 43.6% 42.0% 39.7% 42.1% 42.1% 42.3% 42.3% 42.3% 42.1% 42.1% 42.1% 42.1% 42.2%   
D&A 963 1,071 1,000 1,031 1,060 1,095 1,135 1,178 1,223 1,265 1,301 1,329 1,345   
EBIT 11,581 11,377 10,801 11,830 12,222 12,745 13,232 13,728 14,117 14,525 14,834 15,011 15,028 - 
EBIT margin (%) 40.3% 38.4% 36.3% 38.7% 38.7% 38.9% 38.9% 38.9% 38.7% 38.7% 38.7% 38.7% 38.7%   
Operational taxes 2,612 2,566 2,436 2,668 2,756 2,874 2,984 3,096 3,183 3,275 3,345 3,385 3,389   
NOPAT   8,969 8,811 8,366 9,162 9,466 9,871 10,248 10,632 10,933 11,250 11,489 11,626 11,639 - 
D&A  963 1,071 1,000 1,031 1,060 1,095 1,135 1,178 1,223 1,265 1,301 1,329 1,345   
Operating cash flow 9,932 9,882 9,366 10,193 10,526 10,966 11,383 11,811 12,156 12,514 12,791 12,955 12,984 - 
Δ Working capital (1,186) (123) (82) 8 (20) 5 (23) (24) (54) (20) (16) (9) (1)   
Capex 1,548 1,436 1,189 1,223 1,263 1,310 1,360 1,411 1,459 1,501 1,533 1,552 1,553   
FCFF 7,198 8,323 8,094 8,979 9,243 9,661 10,000 10,377 10,643 10,993 11,242 11,395 11,430 187,015 
Growth (%)   15.6% -2.8% 10.9% 2.9% 2.9% 2.9% 2.9% 2.9% 2.9% 2.9% 2.9% 2.9%   
PV FCFF - - 8094 8378 8047 7848 7580 7339 7024 6769 6459 6109 5717 93547 
Appendix 8 – DCF-model 
Source: PMI respective annual reports and own calculations 
 
 



















Identifier  Company Name Market Cap Revenue EV Dividend Yield 
PM Philip Morris International 130,537,880,702 29,625,000,000 157,701,880,702 5.58% 
BATS.L British American Tobacco 90,263,981,285 31,244,578,252 152,255,571,078 6.78% 
2914.T Japan Tobacco Inc 45,998,160,074 20,226,013,143 54,532,079,117 6.07% 
MO.N Altria Group Inc 93,499,731,826 25,364,000,000 119,929,731,826 6.71% 
IMB.L Imperial Brands PLC 20,848,213,178 38,819,467,483 36,643,609,800 12.33% 
UNA.AS Unilever NV 157,714,072,363 58,470,960,639 185,702,979,775 2.97% 
ABI.BR Anheuser Busch Inbev  132,387,561,489 54,619,000,000 244,760,561,489 2.55% 
PEP.O PepsiCo Inc 190,019,703,509 64,661,000,000 216,887,703,509 2.80% 
MDLZ.O Mondelez International 77,836,905,496 25,938,000,000 95,969,905,496 2.11% 
ROG.S Roche Holding AG 264,053,256,154 57,923,374,771 275,591,561,377 2.87% 
KMB Kimberly-Clark Corp 46,662,698,136 18,486,000,000 54,266,698,136 3.03% 
DGE.L Diageo PLC 94,588,776,732 16,331,996,344 112,322,345,428 2.23% 
CL Colgate-Palmolive Co 58,219,013,865 15,544,000,000 65,920,013,865 2.53% 
MCD Mcdonald's Corp 146,815,543,904 21,025,200,000 191,059,243,904 2.56% 
JNJ Johnson & Johnson 368,435,817,136 81,581,000,000 379,208,817,136 2.71% 
HEIN.AS Heineken NV 60,531,248,048 25,771,859,804 79,726,302,740 1.74% 
KO Coca-Cola Co 230,377,101,341 31,856,000,000 261,835,101,341 2.98% 
NESN.S Nestle SA 310,161,919,223 93,171,999,185 350,958,097,948 2.38% 
PG Procter & Gamble Co 309,906,023,205 67,684,000,000 331,436,023,205 2.40% 
KHC.O Kraft Heinz Co 38,930,601,394 26,268,000,000 67,420,601,394 5.02% 
Appendix 9 – Peer Group 
Source: Thomson Reuters Eikon 12/12/2019 
Source: Thomson Reuters EIKON 
 






































PMI Peer Group P/E  EV/EBITDA P/Sales EV / Revenue 
British American Tobacco PLC 11.27 10.12 2.71 4.59 
Japan Tobacco Inc 12.05 8.27 2.30 2.72 
Altria Group Inc 54.21 11.49 3.72 4.76 
Imperial Brands PLC 15.85 7.32 0.50 0.88 
Unilever NV 15.37 14.91 2.82 3.30 
Anheuser Busch Inbev NV 16.69 11.04 2.44 4.50 
PepsiCo Inc 16.77 16.68 2.88 3.28 
Mondelez International Inc 20.26 18.02 3.03 3.73 
Roche Holding AG 22.19 11.53 4.41 4.58 
Kimberly-Clark Corp 23.22 13.15 2.53 2.94 
Diageo PLC 23.66 19.25 5.59 6.64 
Colgate-Palmolive Co 24.34 15.83 3.76 4.26 
Mcdonald's Corp 25.48 18.59 7.03 9.15 
Johnson & Johnson 26.69 13.19 4.51 4.64 
Heineken NV 29.16 12.43 2.37 3.11 
Coca-Cola Co 30.45 23.16 6.53 7.43 
Nestle SA 33.02 17.45 3.3 3.72 
Procter & Gamble Co 76.96 18.10 4.5 4.82 
Kraft Heinz Co - 10.91 1.54 2.66 
Appendix 10 – Peer Group  
Source: Thomson Reuters Eikon 12/12/2019 
Source: Thomson Reuters EIKON 
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